The Dynamics of Chronic Gout Treatment: Medication Gaps and Return to Therapy

Abstract Objective To identify gaps in therapy with urate-lowering drugs for the treatment of gout as well as factors associated with resuming therapy. Methods From 2 integrated delivery systems, we identified patients 18 years or older with a diagnosis of gout who initiated use of a urate-lowering...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of medicine 2010, Vol.123 (1), p.54-59
Hauptverfasser:	Harrold, Leslie R., MD, MPH, Andrade, Susan E., ScD, Briesacher, Becky, PhD, Raebel, Marsha A., Pharm D, Fouayzi, Hassan, MS, Yood, Robert A., MD, Ockene, Ira S., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adherence Age Factors Aged Allopurinol - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Biological and medical sciences Chi-Square Distribution Chronic Disease Clinical trials Cohort Studies Colchicine - administration & dosage Compliance Diseases of the osteoarticular system Dose-Response Relationship, Drug Drug Administration Schedule Drug therapy Female Follow-Up Studies General aspects Glucocorticoids - administration & dosage Gout Gout - diagnosis Gout - drug therapy Gout Suppressants - administration & dosage Humans Inflammatory joint diseases Internal Medicine Kaplan-Meier Estimate Male Medical sciences Middle Aged Miscellaneous. Osteoarticular involvement in other diseases Patient Compliance - statistics & numerical data Persistence Probability Proportional Hazards Models Rheumatism Risk Assessment Severity of Illness Index Sex Factors Time Factors Treatment Outcome Urate-lowering drugs Uric Acid - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!